Using large scale genome-wide association studies to identify pharmacological targets for osteoporosis intervention [ 2019 - ]

Research Grant

Brief description Osteoporosis is a debilitating genetic bone disease that involves bone loss and increases fracture risk. This project aims to lead the largest ever genetic study of osteoporosis in half a million individuals, and in doing so, combine statistical and molecular approaches to identify genes that could in future serve as osteoporosis drug targets that restore lost bone.

Funding Amount $270,906.00

Funding Scheme Project Grants

Notes New Investigator Grant